Cassava Sciences, Inc.
NASDAQ:SAVA
25.84 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | -0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41.119 | 10.89 | 11.484 | 16.809 | 20.563 | 63.725 | 65.984 | 53.918 | 5.08 | 0 | 0 | 0.114 | 0 | 0 | 0 |
Cost of Revenue
| 89.423 | 1.301 | 0.534 | 0.346 | 0.058 | 0.069 | 0.068 | 0.058 | 0.045 | 0.007 | 0.005 | 0.008 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.158 | -1.539 |
Gross Profit
| -89.423 | -1.303 | -0.534 | -0.346 | -0.058 | -0.069 | -0.068 | -0.058 | -0.045 | -0.007 | 41.114 | 10.882 | 11.484 | 16.809 | 20.563 | 63.725 | 65.984 | 53.918 | 5.08 | 0 | 0 | 0.114 | 0 | 6.158 | 1.539 |
Gross Profit Ratio
| 0 | 723.778 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.999 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 6,158,200 | 1,539,092 |
Reseach & Development Expenses
| 89.423 | 68.032 | 24.813 | 3.053 | 1.568 | 2.969 | 7.615 | 9.176 | 9.1 | 7.306 | 4.917 | 7.605 | 8.3 | 15.746 | 21.059 | 45.817 | 47.73 | 46.803 | 32.938 | 35.093 | 18.913 | 11.396 | 11.668 | 12.596 | 2.092 |
General & Administrative Expenses
| 16.534 | 11.988 | 8.055 | 3.739 | 3.391 | 3.693 | 4.334 | 5.781 | 5.102 | 5.127 | 4.837 | 7.182 | 6.698 | 14.766 | 6.258 | 9.196 | 8.085 | 7.668 | 4.859 | 3.868 | 3.338 | 0 | 5.647 | 7.709 | 0 |
Selling & Marketing Expenses
| -1.53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 16.534 | 11.988 | 8.055 | 3.739 | 3.391 | 3.693 | 4.334 | 5.781 | 5.102 | 5.127 | 4.837 | 7.182 | 6.698 | 14.766 | 6.258 | 9.196 | 8.085 | 7.668 | 4.859 | 3.868 | 3.338 | 5.523 | 5.647 | 7.709 | 2.567 |
Other Expenses
| 0 | 0.997 | 0.434 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -33.838 | 0 | 6.158 | 1.539 |
Operating Expenses
| 15.627 | 80.02 | 32.868 | 6.792 | 4.959 | 6.662 | 11.949 | 14.957 | 14.202 | 12.433 | 9.754 | 14.787 | 14.998 | 30.512 | 27.317 | 55.013 | 55.815 | 54.471 | 37.797 | 38.961 | 22.251 | -16.919 | 17.315 | 26.463 | 6.199 |
Operating Income
| -105.957 | -80.02 | -32.868 | -6.446 | -4.959 | -6.662 | -11.949 | -14.957 | -14.202 | -12.433 | 31.365 | -3.897 | -3.514 | -13.703 | -6.754 | 8.712 | 10.169 | -0.553 | -32.717 | -38.961 | -22.251 | 16.919 | -17.315 | -20.305 | -4.659 |
Operating Income Ratio
| 0 | 44,455 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.763 | -0.358 | -0.306 | -0.815 | -0.328 | 0.137 | 0.154 | -0.01 | -6.44 | 0 | 0 | 148.412 | 0 | -20,304,908 | -4,659,473 |
Total Other Income Expenses Net
| 8.74 | 3.774 | 0.483 | 0.112 | 0.328 | 0.105 | 0.038 | 0.107 | 0.057 | 0.047 | 0.106 | 0.451 | 0.901 | 1.68 | 1.777 | 6.018 | 10.136 | 9.668 | 2.047 | 1.185 | 0.634 | -32.844 | 2.978 | 2.826 | 0.161 |
Income Before Tax
| -97.217 | -76.246 | -32.385 | -6.334 | -4.631 | -6.557 | -11.911 | -14.85 | -14.145 | -12.386 | 31.471 | -3.446 | -2.613 | -12.023 | -4.977 | 14.73 | 20.305 | 9.115 | -30.67 | -37.776 | -21.617 | -15.925 | -14.337 | -17.479 | -4.499 |
Income Before Tax Ratio
| 0 | 42,358 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.765 | -0.316 | -0.228 | -0.715 | -0.242 | 0.231 | 0.308 | 0.169 | -6.037 | 0 | 0 | -139.693 | 0 | -17,478,990 | -4,498,785 |
Income Tax Expense
| 0 | -3.774 | -0.583 | -0.48 | -0.386 | -0.105 | -0.038 | -0.107 | -0.057 | -0.047 | -0.073 | -0.451 | -0.901 | -1.68 | -1.51 | -0.617 | -10.136 | 2.927 | -2.047 | -1.185 | -0.634 | 32.844 | 0.001 | 0.001 | 0.001 |
Net Income
| -97.217 | -72.472 | -31.802 | -5.854 | -4.245 | -6.557 | -11.911 | -14.85 | -14.145 | -12.386 | 31.544 | -3.446 | -2.613 | -12.023 | -3.467 | 15.347 | 20.305 | 6.188 | -30.67 | -37.776 | -21.617 | -15.925 | -14.337 | -17.48 | -4.5 |
Net Income Ratio
| 0 | 40,262 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.767 | -0.316 | -0.228 | -0.715 | -0.169 | 0.241 | 0.308 | 0.115 | -6.037 | 0 | 0 | -139.693 | 0 | -17,479,790 | -4,499,585 |
EPS
| -2.32 | -1.8 | -0.81 | -0.22 | -0.24 | -0.61 | -1.82 | -2.28 | -2.16 | -1.92 | 4.9 | -0.54 | -0.41 | -1.97 | -0.58 | 2.52 | 3.22 | 0.98 | -4.9 | -7.1 | -5.13 | -4.12 | -3.96 | -8.97 | -9.42 |
EPS Diluted
| -2.32 | -1.8 | -0.81 | -0.22 | -0.24 | -0.61 | -1.82 | -2.28 | -2.16 | -1.92 | 4.9 | -0.54 | -0.41 | -1.97 | -0.58 | 2.45 | 3.08 | 0.98 | -4.9 | -7.1 | -5.13 | -4.12 | -3.96 | -8.97 | -9.42 |
EBITDA
| -104.427 | -80.02 | -32.868 | -7.138 | -4.959 | -6.662 | -11.949 | -14.957 | -14.202 | -12.433 | 31.365 | -3.897 | -3.514 | -13.471 | -6.754 | 9.164 | 10.525 | -0.553 | -32.349 | -38.578 | -21.91 | 17.268 | -15.871 | -14.147 | -3.12 |
EBITDA Ratio
| 0 | 44,455 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.763 | -0.358 | -0.306 | -0.801 | -0.328 | 0.144 | 0.16 | -0.01 | -6.368 | 0 | 0 | 151.474 | 0 | -14,146,709 | -3,120,382 |